Hormonal, metabolic, and inflammatory profiles and endometrial cancer risk within the EPIC cohort - A factor analysis

American Journal of Epidemiology

Volumn 177, Issue 8, 2013, Pages 787-799

  Dossus, Laure ^a   Lukanova, Annekatrin ^a   Rinaldi, Sabina ^a   Allen, Naomi ^a   Cust, Anne E ^a   Becker, Susen ^a   Tjonneland, Anne ^a   Hansen, Louise ^a   Overvad, Kim ^a   Chabbert Buffet, Nathalie ^a   Mesrine, Sylvie ^a   Clavel Chapelon, Francoise ^a   Teucher, Birgit ^a   Chang Claude, Jenny ^a   Boeing, Heiner ^a   Drogan, Dagmar ^a   Trichopoulou, Antonia ^a   Benetou, Vasiliki ^a   Bamia, Christina ^a   Palli, Domenico ^a   Agnoli, Claudia ^a   Galasso, Rocco ^a   Tumino, Rosario ^a   Sacerdote, Carlotta ^a   Bueno De Mesquita, H Bas ^a   Van Duijnhoven, Fränzel J B ^a   Peeters, Petra H M ^a   Onland Moret, N Charlotte ^a   Redondo, Maria Luisa ^a   Travier, Noémie ^a   Sanchez, Maria Jose ^a   Altzibar, Jone M ^a   Chirlaque, Maria Dolores ^a   Barricarte, Aurelio ^a   Lundin, Eva ^a   Khaw, Kay Tee ^a   Wareham, Nicholas ^a   Fedirko, Veronika ^a   Romieu, Isabelle ^a   Romaguera, Dora ^a   Norat, Teresa ^a   Riboli, Elio ^a   Kaaks, Rudolf ^a   more..

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

endometrial neoplasms; factor analysis; hormones; inflammation; prospective studies

Indexed keywords

ADIPONECTIN; ANDROSTENEDIONE; BIOLOGICAL MARKER; C PEPTIDE; C REACTIVE PROTEIN; ESTRONE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; TESTOSTERONE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

BIOMARKER; CANCER; CARCINOGEN; COHORT ANALYSIS; ESTROGENIC COMPOUND; FACTOR ANALYSIS; HEALTH RISK; HORMONE; LIFESTYLE; LIPID; PROTEIN; WEIGHT; WOMENS HEALTH;

ADULT; ARTICLE; BODY MASS; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; ENDOMETRIUM CANCER; EUROPE; FACTORIAL ANALYSIS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PROSPECTIVE STUDY;

ADIPONECTIN; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHOLESTEROL; COHORT STUDIES; ENDOMETRIAL NEOPLASMS; ESTROGENS; EUROPEAN UNION; FACTOR ANALYSIS, STATISTICAL; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; INCIDENCE; INFLAMMATION; INTERLEUKIN-1; INTERLEUKIN-6; LIFE STYLE; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SOMATOMEDINS; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA; WAIST CIRCUMFERENCE;

EUROPE;

EID: 84876252959     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kws309     Document Type: Article

References (41)

1. Lee J, Demissie K, Lu SE, et al. Cancer incidence among Korean-American immigrants in the United States and native Koreans in South Korea. Cancer Control. 2007;14(1):78-85.
2. Liao CK, Rosenblatt KA, Schwartz SM, et al. Endometrial cancer in Asian migrants to the United States and their descendants. Cancer Causes Control. 2003;14(4):357-360.
3. Dossus L, Kaaks R. Nutrition, metabolic factors and cancer risk. Best Pract Res Clin Endocrinol Metab. 2008;22(4):551-571.
4. Key TJ, Pike MC. The dose-effect relationship between 'unopposed oestrogens and endometrial mitotic rate:its central role in explaining and predicting endometrial cancer risk. Br JCancer. 1988;57(2):205-212.
5. Lukanova A, Lundin E, Micheli A, et al. Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women. Int JCancer. 2004;108(3):425-432.
6. Zeleniuch-Jacquotte A, Akhmedkhanov A, Kato I, et al. Postmenopausal endogenous oestrogens and risk of endometrial cancer:results of a prospective study. Br JCancer. 2001;84(7):975-981.
7. Henderson BE, Casagrande JT, Pike MC, et al. The epidemiology ofendometrial cancer in young women. Br JCancer. 1983;47(6):749-756.
8. Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancerrisk:a synthetic review. Cancer Epidemiol Biomarkers Prev. 2002;11(12):1531-1543.
9. Lukanova A, Zeleniuch-Jacquotte A, Lundin E, et al. Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer. Int J Cancer. 2004;108(2):262-268.
10. Bjorge T, Stocks T, Lukanova A, et al. Metabolic syndrome and endometrial carcinoma. Am J Epidemiol. 2010;171(8):892-902.
11. Gunter MJ, Hoover DR, Yu H, et al. A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer. Cancer Epidemiol Biomarkers Prev. 2008;17(4):921-929.
12. Maybin JA, Critchley HO, Jabbour HN. Inflammatory pathways in endometrial disorders. Mol Cell Endocrinol. 2011;335(1):42-51.
13. Wallace AE, Gibson DA, Saunders PT, et al. Inflammatory events in endometrial adenocarcinoma. J Endocrinol. 2010;206(2):141-157.
14. Modugno F, Ness RB, Chen C, et al. Inflammation and endometrial cancer:ahypothesis. Cancer Epidemiol Biomarkers Prev. 2005;14(12):2840-2847.
15. Cust AE, Allen NE, Rinaldi S, et al. Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; results from the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2007;120(12):2656-2664.
16. Allen NE, Key TJ, Dossus L, et al. Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer. 2008;15(2):485-497.
17. Cust AE, Kaaks R, Friedenreich C, et al. Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer. 2007; 14(3):755-767.
18. Cust AE, Kaaks R, Friedenreich C, et al. Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women. J Clin Endocrinol Metab. 2007;92(1):255-263.
19. Dossus L, Rinaldi S, Becker S, et al. Obesity, inflammatory markers and endometrial cancerrisk:aprospective case-control study. Endocr Relat Cancer. 2010;17(4):1007-1019.
20. Dossus L, Becker S, Rinaldi S, et al. Tumor necrosis factor (TNF)-α, soluble TNF receptors and endometrial cancerrisk:the EPIC study. Int JCancer. 2010;129(8):2032-2037.
21. Riboli E, Hunt KJ, Slimani N, et al. European Prospective Investigation into Cancerand Nutrition (EPIC):study populations and data collection. Public Health Nutr. 2002; 5(6B):1113-1124.
22. Kaaks R, Berrino F, Key T, et al. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst. 2005;97(10):755-765.
23. Johnson RA, Wichern DW. Applied Multivariate Statistical Analysis. 6th ed. Upper Saddle River, NJ:Prentice-Hall; 2007.
24. Lihn AS, Pedersen SB, Richelsen B. Adiponectin:action, regulation and association to insulin sensitivity. Obes Rev. 2005;6(1):13-21.
25. Miller WM, Nori-Janosz KE, Lillystone M, et al. Obesity and lipids. Curr Cardiol Rep. 2005;7(6):465-470.
26. Gallagher EJ, Leroith D. Insulin, insulin resistance, obesity, and cancer. Curr Diab Rep. 2010;10(2):93-100.
27. Franks S, Kiddy DS, Hamilton-Fairley D, et al. The role of nutrition and insulin in the regulation of sex hormone binding globulin. J Steroid Biochem Mol Biol. 1991;39(5B):835-838.
28. Lee PD, Giudice LC, Conover CA, et al. Insulin-like growth factor binding protein-1:recent findings and new directions. Proc Soc Exp Biol Med. 1997;216(3):319-357.
29. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metab. 2000;11(8):327-332.
30. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860-867.
31. Das UN Is obesity an inflammatory condition? Nutrition. 2001;17(11-12):953-966.
32. Talavera F, Reynolds RK, Roberts JA, et al. Insulin-like growth factor I receptors in normal and neoplastic human endometrium. Cancer Res. 1990;50(10):3019-3024.
33. Roy RN, Gerulath AH, Cecutti A, et al. Discordant expression of insulin-like growth factors and their receptor messenger ribonucleic acids in endometrial carcinomas relative to normal endometrium. Mol Cell Endocrinol. 1999;153(1-2):19-27.
34. Bell SC. The insulin-like growth factorbinding proteins\-the endometrium and decidua. Ann N YAcad Sci. 1991;622:120-137.
35. Tuckerman EM, Okon MA, Li T, et al. Do androgens have a direct effect on endometrial function? An in vitro study. Fertil Steril. 2000;74(4):771-779.
36. Schottenfeld D, Beebe-Dimmer J. Chronic inflammation:a common and important factor in the pathogenesis of neoplasia. CA Cancer J Clin. 2006;56(2):69-83.
37. Greenberg AS, Mc Daniel ML. Identifying the links between obesity, insulin resistance and beta-cell function:potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabetes. Eur J Clin Invest. 2002; 32(suppl 3):24-34.
38. Purohit A, Reed MJ. Regulation of estrogen synthesis in postmenopausal women. Steroids. 2002;67(12):979-983.
39. Zhao Y, Nichols JE, Bulun SE, et al. Aromatase P450 gene expression in human adipose tissue. Role of a Jak/STAT pathway in regulation of the adipose-specific promoter. J Biol Chem. 1995;270(27):16449-16457.
40. Salama SA, Kamel MW, az-Arrastia CR, et al. Effect of tumor necrosis factor-alpha on estrogen metabolism and endometrial cells:potential physiological and pathological relevance. J Clin Endocrinol Metab. 2009; 94(1):285-293.
41. Wang T, Rohan TE, Gunter MJ, et al. A prospective study of inflammation markers and endometrial cancer risk in postmenopausal hormone nonusers. Cancer Epidemiol Biomarkers Prev. 2011;20(5):971-977.